X0300833 | 重组人内皮抑素腺病毒注射液 | | Injection | Biological Products(1) | New Drug Application | 2004-09-21 | 广州达博生物制品有限公司 | Doublle Bioproduct IncGuangzhou PRC | Certificate Issued | 2004-12-24 | view |
CXSL1700067 | 重组人γ-干扰素腺病毒注射液 | | Injection | Biological Products(3) | New Drug Application | 2017-09-05 | 广州达博生物制品有限公司 | Doublle Bioproduct IncGuangzhou PRC | Certificate Issued | 2018-05-30 | view |
CXSB1100019 | 重组人内皮抑素腺病毒注射液 | | Injection | Biological Products | Supplementary Application | 2012-02-03 | 广州达博生物制品有限公司 | Doublle Bioproduct IncGuangzhou PRC | Certificate Issued | 2012-12-25 | view |
CXSL0600043 | 重组人γ-干扰素腺病毒注射液 | | Injection | Biological Products(1) | New Drug Application | 2006-08-20 | 广州达博生物制品有限公司 | Doublle Bioproduct IncGuangzhou PRC | Certificate Issued | 2012-10-30 | view |
CXSL2100067 | 重组人γ-干扰素腺病毒注射液 | | Injection | Biological Products(1) | New Drug Application | 2021-02-24 | 广州达博生物制品有限公司 | Doublle Bioproduct IncGuangzhou PRC | In Review | 2021-02-23 | view |
CXSB0600050 | 重组人内皮抑素腺病毒注射液 | | Injection | Biological Products | Supplementary Application | 2006-06-23 | 广州达博生物制品有限公司 | Doublle Bioproduct IncGuangzhou PRC | Certificate Issued | 2007-06-11 | view |